About Us
Research
Enhance the quality of existing research programs and develop priority programs for the future.
Strategy 2.1- We will strengthen the quality and impact of our basic, translational, clinical and population-based research through superior leadership, infrastructure, resources and efficiencies.
Strategy 2.2- We will improve the diagnosis and treatment of cancer by discovering, validating and targeting specific genetic and molecular abnormalities, altering the organ microenvironment, enhancing immune responses, and better understanding the biology and chemistry of normal and malignant cells and tissues.
Strategy 2.3 - We will invest resources to seize emerging research opportunities and to reward excellence and innovation. *We will leverage our research funds by competing for awards from the Cancer Prevention and Research Institute of Texas.
Strategy 2.4- We will improve our information systems, bioinformatics and computational capabilities to enable us to collect, integrate and analyze large clinical and research databases, and to generate knowledge.
Strategy 2.5 - We will seek to reduce undesired effects of cancer treatment, and develop strategies for enhancing survivorship and managing long-term effects of cancer and its therapy.
Strategy 2.6 - We will convert scientific discoveries into useful products and devices through enhanced technology development and transfer.
*Strategy 2.7- We will create new research programs and expand existing strategic programs that will populate our research institutes and centers of excellence.
*Updated July 2008